Clinical Trial Update: A Trial of CTT1403 for Metastatic Castration Resistant Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial results for CTT1403 in metastatic castration-resistant prostate cancer have been completed with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• CTT1403 (CTT1403)

Snippet

Sponsor: Cancer Targeted Technology | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED | Results posted: 2024-03-21